Solgar, Triple Strength, Shellfish -Free, Glucosamine Chondroitin MSM, 120 Tablets per bottle. Glass Bottle, 12 per Case, Store at room temperature . Product Number -1319

Recall Insight

This FDA Food action (record #F-0803-2024) was formally reported on February 7, 2024, with the manufacturer initiating the action on December 22, 2023. It is classified under Low severity (Class III), with a current status of Terminated. Nestle Product Technology Center - Nestle Health Science is listed as the recalling firm, operating out of Bridgewater, NJ. Federal records indicate 612 bottles units are affected.

The documented reason for this recall is: Nestle Health Science has initiated a recall of Solgar Glucosamine Chondroitin, 120 Tablets, in Glass bottle, 12 bottles per case because of error during packaging in which a A Megasorb B-Complex product was filled into… Distribution data in the federal record shows the product reached: The recalled product was distributed to the following states: NY, IN, PA, TX, TN, NV. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.

To put this record in context, PlainRecalls indexes 83,949 recalls across the FDA, CPSC, NHTSA and USDA FSIS going back to 1995. Within the same product category, the database holds 6 closely related recalls, of which 6 were also issued by FDA Food. That clustering is a signal — repeated actions in a narrow category often indicate a systemic quality-control issue, a supplier-wide contamination, or a design defect that has propagated across product lines. This recall is roughly 2 years old; older recalls can remain relevant because many units enter resale, rental, and secondary-market channels where the original warning never reaches the end user. Always cross-check the recall number against the official agency page before relying on any summary.